Skip Navigation


European Heart Journal Advance Access originally published online on October 24, 2008
European Heart Journal 2008 29(24):2953-2954; doi:10.1093/eurheartj/ehn488
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/24/2953    most recent
ehn488v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in EHJ
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Steg, P. G.
Right arrow Articles by Ducrocq, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steg, P. G.
Right arrow Articles by Ducrocq, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Devices to protect against embolization during primary angioplasty for ST-segment elevation myocardial infarction: the good, the bad and the ugly

P. Gabriel Steg* and Gregory Ducrocq

INSERM U-698, Université Paris 7 – Denis Diderot, AP-HP, Paris, France

* Corresponding author. Tel: +33 1 4025 8668, Fax: +33 1 4025 8865, Email: gabriel.steg@bch.aphp.fr

This editorial refers to ‘Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials’{dagger} by A.A. Bavry et al., on page 2989

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 10% of the full text of this article appears below.

Primary angioplasty is the established treatment for recanalization of coronary arteries during acute ST-segment elevation myocardial infarction (STEMI). However, due to the large thrombus burden encountered during the procedure, there is a high frequency of distal embolization, which contributes to no-reflow, and reduces the benefit of timely reperfusion. In the past, there have been many attempts to solve this . . . [Full Text of this Article]

Is another trial warranted?


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in EHJ:

Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials
Anthony A. Bavry, Dharam J. Kumbhani, and Deepak L. Bhatt
EHJ 2008 29: 2989-3001. [Abstract] [Full Text]